
Loading, please wait...

Loading, please wait...

Psoriasis presents as a chronic inflammatory skin condition that significantly impacts patient quality of life. Current clinical management often remains unsatisfactory due to persistent adverse effects and unmet needs. However, researchers have recently focused on **TRP channel psoriasis therapy** as a transformative approach to treatment. These Transient Receptor Potential (TRP) channels serve as non-selective cation sensors within the skin. Consequently, they regulate critical processes such as keratinocyte proliferation and immune cell infiltration. Furthermore, evidence suggests that altered expression of these channels contributes directly to psoriatic lesions.
Multiple TRP subtypes play distinct roles in the pathogenesis of this disease. Specifically, patients often show altered levels of vanilloid subtypes, including TRPV1, TRPV3, TRPV4, and TRPV6. Moreover, the canonical TRPC6 and melastatin TRPM8 channels influence cellular signaling. These channels stimulate sensory neurons and drive the activation of T lymphocytes and macrophages. Therefore, modulating these specific pathways could halt the cycle of hyperproliferation and inflammation. Additionally, the pharmacological targeting of these channels offers a path toward more efficacious and safer dermatological interventions.
The therapeutic potential of modulating these channels is already visible in existing treatments. For example, some topical pharmacotherapies and phototherapies inadvertently activate TRPV1 and TRPA1, causing side effects. Conversely, the repeated application of the TRPV1 agonist capsaicin induces channel desensitization. This process effectively reduces both pruritus and the clinical severity of psoriasis. Thus, developing precise pharmacological modulators represents a promising strategy for future care. Emerging studies continue to validate these channels as viable targets for novel drug development. In conclusion, the transition toward TRP-focused treatments may finally address the systemic complexities of psoriatic disease.
TRP channels are cellular sensors that control the flow of cations into cells. In psoriasis, they are overexpressed or dysfunctional, leading to excessive skin cell growth and immune system overactivity.
Capsaicin acts as a TRPV1 agonist. Repeated treatment desensitizes the channel, which reduces the inflammatory response and alleviates the intense itching often associated with psoriatic plaques.
Researchers aim to develop TRP modulators that target specific cellular pathways. This precision may offer a better safety profile compared to the broad immunosuppression or skin-thinning risks associated with long-term steroid use.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
da Silva AM et al. Role of transient receptor potential channels on pathogenesis and treatment of psoriasis. Inflammopharmacology. 2026 Feb 14. doi: 10.1007/s10787-025-02095-0. PMID: 41689746.
Riol-Blanco L, et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature. 2014;510(7506):548-552.
Ozcan O, et al. Expression of transient receptor potential vanilloid 1 (TRPV1) in patients with psoriasis. Adv Dermatol Allergol. 2021;38(4):645-651.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of TRP channels in psoriasis, highlighting subtypes like TRPV1 and TRPC6 as targets for novel, safer, and more effective dermatological treatments....
6 months ago

As GLP-1 receptor agonists reshape obesity management, preserving lean muscle mass and preventing nutritional gaps have become essential clinical priorities. Explore how targeted nutritional science, high-protein formulations, and dietary strategies optimize long-term health outcomes for patients during rapid weight loss.
Today

Although traditional safe motherhood initiatives expanded healthcare access, high maternal mortality persists. Prioritizing emergency obstetric care, optimizing signal functions, and strengthening referral networks are crucial to saving maternal and newborn lives during acute intrapartum crises.
Today

Clinicians frequently utilize etomidate for brief procedural sedation due to its stable hemodynamics. However, paradoxical agitation can occasionally emerge following administration. This review examines a rare case during electrical cardioversion, exploring causative mechanisms, diagnosis, and management.
Today

Internationally trained Indian clinicians are spearheading a quiet revolution across surgical and medical specialties. By integrating advanced robotics, AI-driven diagnostics, and standardized protocols, modern clinical practice is shifting toward personalized, precision-focused treatment to improve patient outcomes.
Today

A multicentre Australian cohort provides new evidence on adjunctive metformin therapy in pregnant women with type 1 diabetes. Using continuous glucose monitoring, researchers demonstrated increased time in range and reduced glycaemic variability without increasing maternal hypoglycaemic episodes.
Today